Immunohistochemical stainings confirmed that the levels of HAS1 and HAS3 were relatively low in ovarian cancers, while the signal for HAS2 was more widespread, in line with the real-time RT-PCR-analysis. Here, HAS3 is linked to ovarian cancer.